177 related articles for article (PubMed ID: 26541602)
1. Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.
Leduc V; Théroux L; Dea D; Dufour R; Poirier J
J Mol Neurosci; 2016 Jan; 58(1):109-19. PubMed ID: 26541602
[TBL] [Abstract][Full Text] [Related]
2. Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.
Leduc V; Bourque L; Poirier J; Dufour R
Pharmacogenet Genomics; 2016 Jan; 26(1):1-11. PubMed ID: 26466344
[TBL] [Abstract][Full Text] [Related]
3. Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese.
Chang XL; Tan L; Tan MS; Wang HF; Tan CC; Zhang W; Zheng ZJ; Kong LL; Wang ZX; Jiang T; Yu JT; Tan L
Oncotarget; 2016 Apr; 7(16):22746-51. PubMed ID: 27009838
[TBL] [Abstract][Full Text] [Related]
4. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
[TBL] [Abstract][Full Text] [Related]
5. Association study of rs3846662 with Alzheimer's disease in a population-based cohort: the Cache County Study.
Wright SM; Jensen SL; Cockriel KL; Davis B; Tschanz JT; Munger RG; Corcoran CD; Kauwe JSK
Neurobiol Aging; 2019 Dec; 84():242.e1-242.e6. PubMed ID: 30975575
[TBL] [Abstract][Full Text] [Related]
6. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.
Burkhardt R; Kenny EE; Lowe JK; Birkeland A; Josowitz R; Noel M; Salit J; Maller JB; Pe'er I; Daly MJ; Altshuler D; Stoffel M; Friedman JM; Breslow JL
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2078-84. PubMed ID: 18802019
[TBL] [Abstract][Full Text] [Related]
7. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
8. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
9. Isoprenoids and tau pathology in sporadic Alzheimer's disease.
Pelleieux S; Picard C; Lamarre-Théroux L; Dea D; Leduc V; Tsantrizos YS; Poirier J
Neurobiol Aging; 2018 May; 65():132-139. PubMed ID: 29476987
[TBL] [Abstract][Full Text] [Related]
10. Protein markers for Alzheimer disease in the frontal cortex and cerebellum.
Verdile G; Gnjec A; Miklossy J; Fonte J; Veurink G; Bates K; Kakulas B; Mehta PD; Milward EA; Tan N; Lareu R; Lim D; Dharmarajan A; Martins RN
Neurology; 2004 Oct; 63(8):1385-92. PubMed ID: 15505153
[TBL] [Abstract][Full Text] [Related]
11. Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes.
Azizidoost S; Babaahmadi-Rezaei H; Nazeri Z; Cheraghzadeh M; Kheirollah A
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159069. PubMed ID: 34744007
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin.
Medina MW; Gao F; Ruan W; Rotter JI; Krauss RM
Circulation; 2008 Jul; 118(4):355-62. PubMed ID: 18559695
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
14. HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study.
Leduc V; De Beaumont L; Théroux L; Dea D; Aisen P; Petersen RC; ; Dufour R; Poirier J
Mol Psychiatry; 2015 Jul; 20(7):867-73. PubMed ID: 25023145
[TBL] [Abstract][Full Text] [Related]
15. HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.
Yu CY; Theusch E; Lo K; Mangravite LM; Naidoo D; Kutilova M; Medina MW
Hum Mol Genet; 2014 Jan; 23(2):319-32. PubMed ID: 24001602
[TBL] [Abstract][Full Text] [Related]
16. Association of the functional variant in the 3-hydroxy-3-methylglutaryl-coenzyme a reductase gene with low-density lipoprotein-cholesterol in Japanese.
Hiura Y; Tabara Y; Kokubo Y; Okamura T; Goto Y; Nonogi H; Miki T; Tomoike H; Iwai N
Circ J; 2010 Mar; 74(3):518-22. PubMed ID: 20145341
[TBL] [Abstract][Full Text] [Related]
17. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
18. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
19. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
[TBL] [Abstract][Full Text] [Related]
20. Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques.
Mann DM; Takeuchi A; Sato S; Cairns NJ; Lantos PL; Rossor MN; Haltia M; Kalimo H; Iwatsubo T
Neuropathol Appl Neurobiol; 2001 Jun; 27(3):189-96. PubMed ID: 11489138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
